1. Linking reproductive tract microbiota to premature ovarian insufficiency: Pathophysiological mechanisms and therapies.
- Author
-
Zhao X, Shi W, Li Z, and Zhang W
- Subjects
- Animals, Female, Humans, Dysbiosis immunology, Dysbiosis microbiology, Genitalia, Female microbiology, Genitalia, Female immunology, Ovary immunology, Ovary microbiology, Probiotics therapeutic use, Probiotics administration & dosage, Microbiota immunology, Primary Ovarian Insufficiency immunology, Primary Ovarian Insufficiency microbiology, Primary Ovarian Insufficiency therapy
- Abstract
Over the past decade, research on the human microbiota has become a hot topic. Among them, the female reproductive tract (FRT) also has a specific microbiota that maintains the body's health and dynamic balance, especially in the reproductive aspect. When the FRT ecosystem is dysregulated, changes in immune and metabolic signals can lead to pathological and physiological changes such as chronic inflammation, epithelial barrier disruption, changes in cell proliferation and apoptosis, and dysregulation of angiogenesis and metabolism, thereby causing disruption of the female endocrine system. Premature ovarian insufficiency (POI), a clinical syndrome of ovarian dysfunction, is primarily influenced by immune, genetic, and environmental factors. New evidence suggests that dysbiosis of the FRT microbiota and/or the presence of specific bacteria may contribute to the occurrence and progression of POI. This influence occurs through both direct and indirect mechanisms, including the regulation of estrogen metabolism. The use of probiotics or microbiota transplantation to regulate the microbiome has also been proven to be beneficial in improving ovarian function and the quality of life in women with premature aging. This article provides an overview of the interrelationships and roles between the FRT microbiome and POI in recent years, to fully understand the risk factors affecting female reproductive health, and to offer insights for the future diagnosis, treatment, and application of the FRT microbiome in POI patients., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.) more...
- Published
- 2024
- Full Text
- View/download PDF